Oncology News Australia

03/01/2026

PBS Update: ZYTORVI™ (toripalimab) is the first and only PBS reimbursed immunotherapy for eligible patients with recurrent locally advanced/metastatic nasopharyngeal carcinoma (R/M NPC). Read more here: t.ly/OyAd4

24/12/2025

2025 Oncology Journal Club Podcast End of Year Special

Hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson. Listen here: https://oncologynetwork.com.au/s3e11-the-oncology-journal-club-podcast/

The team reflect on the achievements of 2025, highlighting key developments, initiatives and papers that have made — and will continue to make — a real impact on clinical practice. As CJ says, it’s a privilege to work in what is the “single most innovative and thoughtful field in all of medicine” — and we are indeed lucky to have our brains tickled every month by this wonderful podcast.

And of course, it wouldn’t be OJC without some laughs and a few naughty jokes — and this year, we even have the inaugural OJC Christmas haiku!

Thank you for listening. We hope you enjoy the final episode of The Oncology Journal Club for 2025.

20/12/2025

Want to Low Down on HER2 Ultralow? Check out the latest episode of the Beyond the Slide podcast

Associate Professor Ben Dessauvagie and Professor Gelareh Farshid join our Host Rachael Babin to explore what this emerging category means for pathologists in the lab and for oncologists making treatment decisions in the clinic.

Exclusive to The Oncology Network: https://oncologynetwork.com.au/breast-episode-6-her2-uncovered/

14/12/2025

📢 New episode alert!
Dive into The Oncology Journal Club 🎧 S3E10: I am large, I contain multitudes!
Expert insights on cancer control measures, the microbiome & surprising research highlights — all delivered with sharp analysis & a bit of humour.
Listen now 👉 https://oncologynews.com.au/podcasts/s3e10-the-oncology-journal-club/

Hosted by Professor Craig Underhill with Dr. Kate Clarke and Professor Christopher Jackson

06/11/2025

🎙 The Oncology Journal Club: ESMO 2025 Special – Part 2 | Listen now: t.ly/SU-WN

Dr Kate Clarke takes the reins in this lively follow-up episode as Professor Craig Underhill dives into the key GU and lung highlights from ESMO 2025.

With witty commentary and a London Global Cancer Week sneak preview by Professor Christopher Jackson.

Expect nuanced analysis, sharp insights and the usual OJC banter!

29/10/2025

🎙️ Heads up oncology fans and data nerds! 🧠 🔬
It’s time for some serious journal-club shenanigans in episode S3E8 – The Oncology Journal Club: ESMO 2025 Special (Part 1)!

Hosted by the dream team: Professor Craig Underhill + Dr Kate Clarke + Professor Christopher Jackson.

What’s on the agenda?
👉 Ovarian, breast, melanoma & GI cancers from the ESMO 2025 congress (Part 1)
👉 Journal papers broken down so you don’t have to squint at tiny print
👉 A few cheeky jokes (yes, we promise)
👉 A downloadable bingo card if you really want to gamify it.

Whether you’re in the clinic, the lab, or on your couch with headphones on — tune in and level up your oncology-smarts in style 🚀

🔗 t.ly/9jcLh — don’t miss it!

28/10/2025

🧬 Calling all gastro-intestinal oncology professionals and researchers!
There's still time to register for the AGITG 27th Annual Scientific Meeting — 24-27 November 2025 in Tarntanya / Adelaide.

The theme “Transforming Trials through Collaboration” invites us to connect, share and move forward together.

You can learn more about the program highlights in our Special Preview podcast here: t.ly/ly9fx

📍 Why attend?

Workshops and symposia with leading national and international experts

Opportunities for meaningful networking across all disciplines

A focus on equity and inclusion — ensuring voices from regional, rural and remote areas are heard.

🔗 Register now: t.ly/0Tb2K

Experts On Point AGITG ASM 2025: Special Podcast Preview By ONA Editor October 16, 2025 No Comments Share Tweet Pinterest LinkedIn Tumblr Email + AGITG ASM 2025 Special | with Associate Professor Sina Vatandoust and Associate Professor Margaret Lee 24–27 November | Tarntanya (Adelaide), South Aust...

22/10/2025

🎙️ We're thrilled to share a new podcast - our AGITG ASM 2025: Special Podcast Preview

In this episode, host Rachael Babin sits down with two stellar guests: Associate Professor Sina Vatandoust (AGITG ASM 2025 Convenor) and Associate Professor Margaret Lee (one of the local speakers).

They discuss how collaboration across Australia, the Asia-Pacific and beyond is helping translate promising concepts into clinical trials that make a real difference.

Key themes include:
• Early-onset cancer
• Global oncology insights
• Radiation oncology breakthroughs
• Survivorship at the heart of the conversation

For anyone working in gastro-intestinal cancers, clinical research or looking to stay ahead of emerging trials and collaborations, this is a great listen.

Tune in and get inspired ahead of AGITG ASM 2025 (24-27 Nov, Tarntanya/Adelaide).

👉 Listen via:

Our website: t.ly/ZKF16
Apple Podcasts: t.ly/9LDeX
Spotify: t.ly/6dond
YouTube: https://www.youtube.com/watch?v=f0ZmYdfLFu8

With thanks to the Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute

24/09/2025

"Radiotherapy f***s vaginas. I'd rather have a robot in my pelvis." Our unfiltered oncology experts tackle robotic surgery benefits, revolutionary RNA vaccines for pancreatic cancer and why removing the spleen might compromise cancer outcomes.

Check out the latest episode of The Oncology Journal Club Podcast, with thanks to Prof. Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson

Listen here: https://oncologynetwork.com.au/s3-e7-the-oncology-journal-club/
Also on YouTube: https://www.youtube.com/watch?v=V8c0ZWi61lE&t=97s

And Spotify, Apple Podcasts etc:

21/08/2025

No more 'hot potatoes'!

Genetic testing is transforming breast cancer care - it's the responsibility of the wider multi-disciplinary team (MDT).

But how can busy MDTs confidently integrate it into everyday practice?

In this episode of Beyond the Slide, Rachael Babin is joined by genetic counsellor Amy Pearn and breast surgeon A/Prof Kylie Snook to unpack practical strategies, demystify Medicare item numbers and share tools to support clinicians.

Tune in for expert tips to help you deliver more personalised care and stay ahead of evolving practice.

https://oncologynetwork.com.au/breast-episode-5-mainstreaming-with-confidence/

27/07/2025

🚨 New Episode Alert! 🎧

Season 3, Episode 6 of The Oncology Journal Club is now live!

Join Professor Craig Underhill, Dr. Kate Clarke and Professor Christopher Jackson as they explore the latest in cancer research and care.

In this episode, they discuss:

🧬 Non-operative management of MMR-deficient tumours
📊 New global standards for clinical trial design
🎯 Advances in HER2-negative metastatic breast cancer
🌈 Conversations about hope, optimism and survival
🍼 Fertility preservation guidelines
And much more!

It’s a fast-paced, insightful episode packed with expert analysis, clinical pearls and trademark humour. Listen here for Show Notes t.ly/9iz1C or wherever you get your podcasts.

13/07/2025

NEW PODCAST ALERT! https://oncologynetwork.com.au/breast-episode-5-mainstreaming-with-confidence/
In the latest episode of Beyond the Slide, we explore one of the most significant shifts in modern breast cancer care — genetic mainstreaming.

Join host Rachael Babin for a practical conversation with genetic counsellor Amy Pearn and breast surgeon Associate Professor Kylie Snook, as they share insights and real-world strategies to help MDTs confidently integrate genetic testing into routine practice.

What’s covered:

- Understanding the benefits and timing of genetic testing in breast cancer
- Medicare item numbers explained — 73295 and 73296 demystified
- Tools to support clinicians, including the Genetics Advisor tool and EviQ education modules
- Common barriers and how to overcome them
- Why mainstreaming matters — for both patients and their families

Perfect for clinicians wanting to upskill and implement genetic mainstreaming confidently in their practice. Listen for expert tips to help you stay ahead of evolving practice and deliver more personalised cancer care.